Heart disease in Denmark: Incidence, risk factors and treatment;Hjertesygdom i Danmark: Sygdomsforekomst, risikofaktorer og behandling

Ugeskrift for Laeger

Volumn 166, Issue 14, 2004, Pages 1320-1327

  Madsen, Mette ^a   Rasmussen, Søren ^a   Abildstrøm, Steen Z ^a   Kjøller, Mette ^a   Jørgensen, Torbed ^a  

^a UNIVERSITY OF SOUTHERN DENMARK   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; ANTIANGINA PECTORIS AGENT; ANTIVITAMIN K; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM ANTAGONIST; CALCIUM CHANNEL BLOCKING AGENT; DIGOXIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; STATINE DERIVATIVE;

ACUTE HEART INFARCTION; DENMARK; DIAGNOSTIC TEST; DISEASE SEVERITY; HEART DISEASE; HUMAN; INCIDENCE; ISCHEMIC HEART DISEASE; MORTALITY; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PHYSICAL ACTIVITY; PREVALENCE; REVIEW; RISK FACTOR; SENSITIVITY ANALYSIS; SMOKING; SURVIVAL; WESTERN EUROPE;

DENMARK; HUMANS; INCIDENCE; MYOCARDIAL INFARCTION; MYOCARDIAL ISCHEMIA; RISK FACTORS; SURVIVAL RATE;

EID: 1842482194     PISSN: 00415782     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (39)

1. Forslag til national strategi for sundhedsvidenskab. København: Forskningsministeriet, 1995.
2. Videbæk J, Madsen M. Hjertestatistik 2000-2001. København: Hjerteforeningen, Statens Institut for Folkesundhed, 2002.
3. Sans S, Kesteloot H, Kromhout D. The burden of cardiovascular diseases in Europe. Eur Heart J 1997;18:1231-48.
4. Tunstall-Pedoe H, Vanuzzo D, Hobbs M et al. Estimation of contribution of changes in coronary care to improving survival, event rates, and coronary heart disease mortality across the WHO MONICA Project populations. Lancet 2000;355:688-700.
5. Tunstall-Pedoe H, Kuulasmaa K, Mahonen M et al. Contribution of trends in survival and coronary-event rates to changes in coronary heart disease mortality: 10-year results from 37 WHO MONICA project populations. Lancet 1999;353:1547-57.
6. Kjøller M, Rasmussen NK. Sundhed & sygelighed i Danmark 2000: & udviklingen siden 1987. København: Statens Institut for Folkesundhed, 2002.
7. Lægemiddelstatistik 1994-1998. Danmark. København: Lægemiddelstyrelsen, 1999.
8. Lægemiddelstatistik 1998-2002 Danmark. København: Lægemiddelstyrelsen, 2003.
9. Glumer C, Jorgensen T, Borch-Johnsen K. Prevalences of diabetes and impaired glucose regulation in a Danish population: the Inter99 study. Diabetes Care 2003;26:2335-40.
10. Capewell S, Beaglehole R, Seddon M et al. Explanation for the decline in coronary heart disease mortality rates in Auckland, New Zealand, between 1982 and 1993. Circulation 2000;102:1511-6.
11. McGovern PG, Pankow JS, Shahar E et al. Recent trends in acute coronary heart disease - mortality, morbidity, medical care, and risk factors. The Minnesota Heart Survey Investigators. N Engl J Med 1996;334:884-90.
12. Rosamond WD, Chambless LE, Folsom AR et al. Trends in the incidence of myocardial infarction and in mortality due to coronary heart disease, 87 to 1994. N Engl J Med 1998;339:861-7.
13. Hunink MG, Goldman L, Tosteson AN et al. The recent decline in mortality from coronary heart disease, 1980-1990. JAMA 1997;277:535-42.
14. Brønnum-Hansen H. Comparing prevent simulations with other methods of risk factor modelling. I: Baan C, ed. Public health models. Tools for health policy making at national and European level. Biomed project BMH4-CT95-1000. Amsterdam: Institut voor Sociale Geneeskunde, Universiteit van Amsterdam, 1999: 89-100.
15. Juel K, Sjol A. Decline in mortality from heart disease in Denmark: some methodological problem. J Clin Epidemiol 1995;48:467-72.
16. Mahonen M, Salomaa V, Brommels M et al. The validity of hospital discharge register data on coronary heart disease in Finland. Eur J Epidemiol 1997;13:403-15.
17. Pell JP, Simpson E, Rodger JC et al. Impact of changing diagnostic criteria on incidence, management, and outcome of acute myocardial infarction: retrospective cohort study. BMJ 2003;326:134-5.
18. Boyle CA, Dobson AJ. The accuracy of hospital records and death certificates for acute myocardial infarction. Aust N Z J Med 1995;25:316-23.
19. Madsen M, Davidsen M, Rasmussen S et al. The validity of the diagnosis of acute myocardial infarction in routine statistics: a comparison of mortality and hospital discharge data with the Danish MONICA registry. J Clin Epidemiol 2003;56:124-30.
20. Osler M, Rostgaard K, Sorensen TI et al. The effect of recurrent events on register-based estimates of level and trends in incidence of acute myocardial infarction. J Clin Epidemiol 1999;52:595-600.
21. Beaglehole R. International trends in coronary heart disease mortality and incidence rates. J Cardiovasc Risk 1999;6:63-8.
22. Beaglehole R, Stewart AW, Jackson R et al. Declining rates of coronary heart disease in New Zealand and Australia, 1983-1993. Am J Epidemiol 1997; 145:707-13.
23. Hammar N, Ahlbom A, Sandberg E et al. Time trends in the incidence of and mortality from acute myocardial infarction in Swedish women. Epidemiology 1996;7:654-5.
24. Linnersjo A, Hammar N, Gustavsson A et al. Recent time trends in acute myocardial infarction in Stockholm, Sweden. Int J Cardiol 2000;76:17-21.
25. Salomaa V, Rosamond W, Mahonen M. Decreasing mortality from acute myocardial infarction: effect of incidence and prognosis. J Cardiovasc Risk 1999; 6:69-75.
26. Rosen M, Alfredsson L, Hammar N et al. Attack rate, mortality and case fatality for acute myocardial infarction in Sweden during 1987-95. J Intern Med 2000;248:159-64.
27. Abildstrom SZ, Rasmussen S, Rosen M et al. Trends in incidence and case fatality rates of acute myocardial infarction in Denmark and Sweden. Heart 2003;89:507-11.
28. Myocardial infarction redefined - a consensus document of The Joint European Society of CardiologyAmerican College of Cardiology Committee for the redefinition of myocardial infarction. Eur Heart J 2000;21:1502-13.
29. Abildstrom SZ, Rasmussen S, Madsen M. Significant decline in case fatality after acute myocardial infarction in Denmark - a population-based study from 1994 to 2001. Scand Cardiovasc J 2002;36:287-91.
30. Graven T, Kruger O, Bronstad G. Epidemiological consequences of introducing new biochemical markers for detection of acute myocardial infarction. Scand Cardiovasc J 2001;35:233-7.
31. Madsen M, Rasmussen S, Juel K. Akut myokardieinfarkt i Danmark: udvikling i incidens og prognose gennem 20 år i Danmark. Ugeskr Læger 2000;162:5918-23.
32. Hellermann JP, Reeder GS, Jacobsen SJ et al. Longitudinal trends in the severity of acute myocardial infarction: a population study in Olmsted County, Minnesota. Am J Epidemiol 2002;156:246-53.
33. Stamler J, Stamler R, Neaton JD et al. Low risk-factor profile and long-term cardiovascular and noncardiovascular mortality and life expectancy: findings for 5 large cohorts of young adult and middle-aged men and women. JAMA 1999;282:2012-8.
34. Hopkins PN, Williams RR. A survey of 246 suggested coronary risk factors. Atherosclerosis 1981;40:1-52.
35. Lundvall O, Asplund K, Cohen D et al. Att Förebygsa sjukdom i hjärta och kärl genom befolknings-riktade program - en systematisk litteraturöversikt. Rapport nr. 134. Stockholm SBU (Statens Beredning för Utvärdering av medicinsk metodik), 1997.
36. Ebrahim S, Davey Smith G. Multiple risk factor interventions for primary prevention of coronary heart disease (Cochrane Review). In: The Cochrane Library, Issue 1, 2004. Oxford: Update Software.
37. Pan XR, Li GW, Hu YH et al. Effects of diet and exercise in preventing NIDDM in people with impaired glucose tolerance. The Da Qing IGT and Diabetes Study. Diabetes Care 1997;20:537-44.
38. Jørgensen T, Borch-Johnsen K, Thomsen TF et al. A randomised non-pharmacological intervention study for prevention of ischaemic heart disease. Eur J Cardiovasc Risk Rehab 2003;10:377-86.
39. EUROASPIRE. A European Society of Cardiology survey of secondary prevention of coronary heart disease: principal results. EUROASPIRE Study Group. European Action on Secondary Prevention through Intervention to Reduce Events. Eur Heart J 1997;18:1569-82.